WHO review of Chinese vaccines for emergency use raises anxiety

There is renewed unease around the safety of China’s domestic vaccines as the WHO says it will review whether they can be approved for emergency use.

One cause of the unease is that the WHO said on the 22nd that it will review China National Pharmaceutical Group’s New Crown vaccine next Monday to decide whether to approve it for emergency use, followed by the approval of the China Kexing vaccine on May 3. But China’s domestic vaccine has been criticized for incomplete data from phase III clinical trials, and the problem has not been fully resolved.

Another reason is the news of a Korean expatriate living in Shanghai, China, who died 3 days after receiving the Chinese vaccine. According to Yonhap News Agency on March 22, the Korean expatriate, who had no underlying disease, had an abnormal reaction such as nausea after receiving the Chinese domestic national vaccine at a hospital in Shanghai on March 19, but unfortunately died 3 days later.

What this raises is a deeper issue, one that stands out exceptionally in contrast to Western countries where vaccination is being vigorously pursued. In Western countries, even if the use of vaccines, adverse reactions caused by vaccination, or even deaths are not fully proved to be necessarily causally related to the vaccine for a while, they are announced in a timely manner because human lives are at stake, for example, a very small number of people have serious adverse reactions after receiving AstraZeneca vaccine, and even individual deaths are such cases, and many countries have made the decision to temporarily stop vaccination for a while. But in mainland China, there is hardly any news in this regard. There are hundreds of millions of people in China who have been vaccinated with the GMP or Kexing vaccine, so why has no data been released on side effects or whether there have been individual deaths? Science writer Fang Zhouzi tweeted, “A 40-something-year-old Korean expatriate in Shanghai died after receiving the Chinese medicine vaccine, with no underlying disease. Chinese vaccines are only suitable for Chinese people as well as Chinese medicine, and there are never any reports in the Chinese media of Chinese people dying after receiving the Chinese New Crown vaccine.” Fang Zhouzi wrote in another tweet a few days ago, “Seven people in Thailand had blood clots and partial paralysis after receiving the Coxin vaccine, and got better after treatment to dissolve the blood clots. This kind of thing is not reported in China, there is no record, so Hu Xijin said that Chinese vaccines have the best safety record in the world.”

The following story is related to Hu Xijin. Hu Xijin, editor-in-chief of the Global Times, recently said that someone could help him get the U.S. Pfizer vaccine but he would rather get a domestic vaccine, a statement that raised another layer of suspicion. Hu Xijin said on Weibo: “Before the vaccination, someone said he could help me get Pfizer vaccination. I said forget it, whether it really works as well as it says it does not know …… The company’s main goal is to provide the best possible service to its customers.

The company’s main goal is to provide the best possible service to its customers. The netizen’s statement caused a debate, Hu Xijin’s intention is to show his patriotism, but from this incident reveals a certain skepticism about domestic vaccines, as well as suspicion of Pfizer vaccines already smuggled in China u. A netizen said: “Old Hu’s words leaked several secrets, one is that Pfizer has indeed come to our country; two is that Pfizer supply exceeds demand, the supply of objects The level is quite high …… The third is that ‘get to’ and other corrupt practices explicitly prohibited by the central government are still prevalent, and the parties can be publicized through microblogging, in a dignified manner.”

A total of five new crown vaccines are currently approved for use in China.